Annual report pursuant to Section 13 and 15(d)

Stock Options

v3.21.2
Stock Options
12 Months Ended
Aug. 31, 2020
Share-based Payment Arrangement [Abstract]  
STOCK OPTIONS
19. STOCK OPTIONS

(a) Stock option plan

The Company has a stock option plan which allows the Board of Directors of the Company to grant options to acquire common shares of the Company to directors, officers, key employees and consultants. The option price, term and vesting are determined at the discretion of the Board of Directors, subject to certain restrictions as required by the policies of the TSX Venture Exchange. The stock option plan is a 20% fixed number plan with a maximum of 54,890,067 common shares reserved for issue at August 31, 2020.


On August 7, 2020, the Company issued a five-year option exercisable for 3,000,000 common shares, vesting over nine months, at an exercise price of CAD$0.085 per share to its newly appointed Chief Operating Officer.


On August 20, 2020, the Company issued a six-month option exercisable for 2,220,000 common shares, vesting immediately, at an exercise price of CAD$0.11 per share to a lender.


During the year ended August 31, 2020 the share-based compensation expense of $887,818 (2019 - $916,240) relates to the vesting of options granted during the current fiscal year and the fiscal year ended August 31, 2018.


(b) Stock options

Stock option transactions under the stock option plan were: 


    Year ended
August 31,  2020
    Year ended
August 31, 2019
 
    Number of Options     Weighted
average
exercise
price
    Number of options     Weighted
average
exercise
price
 
Balance, beginning of period     9,808,333     CAD$       1.20       9,858,333     CAD$       1.22  
Options granted     5,220,000     CAD$ 0.10       -       -  
Options forfeited     (5,558,333 )   CAD$ 1.14       (50,000 )   CAD$ 4.80  
Balance, end of period     9,470,000     CAD$ 0.63       9,808,333     CAD$ 1.20  

Stock options outstanding and exercisable as at August 31, 2020 are:


Expiry Date   Exercise
Price
    Options
Outstanding
    Options
Exercisable
 
February 20, 2021   CAD$ 0.110       2,220,000       2,220,000  
August 7, 2025   CAD$ 0.085       3,000,000       -  
November 30, 2027   CAD$ 2.270       950,000       950,000  
June 5, 2028   CAD$ 1.000       3,300,000       2,475,000  
              9,470,000       5,645,000  
Weighted average remaining contractual life             5.1 years       4.8 years  

The total grant-date fair value of stock options granted during the year ended August 31, 2020 was $259,220, determined by applying the Black-Scholes option pricing model with the following inputs and assumptions:


    Year ended
August 31,
2020
 
Conversion price     CAD$0.085 to CAD$0.11  
Risk free interest rate     0.19 to 0.30 %
Expected life of derivative liability     0.5 to 5 years  
Expected volatility of underlying stock     135 to 192 %
Expected dividend rate     0 %